Les leucotriènes : des cibles thérapeutiques potentielles dans le traitement des maladies cardiovasculaires

Bäck, 2002, Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle, Acta Physiol. Scand. Suppl., 648, 1 Brezinski, 1992, Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy, Circulation, 86, 56, 10.1161/01.CIR.86.1.56 Dwyer, 2004, Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis, N. Engl. J. Med., 350, 29, 10.1056/NEJMoa025079 Bäck, 2002, Functional characteristics of cysteinyl-leukotriene receptor subtypes, Life Sci., 71, 611, 10.1016/S0024-3205(02)01733-2 Bäck, 2000, Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes, Eur. J. Pharmacol., 401, 389, 10.1016/S0014-2999(00)00453-2 Bäck, 2004, Leukotriene B4 is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptor, Am. J. Physiol. Heart Circ. Physiol., 287, H419, 10.1152/ajpheart.00699.2003 Bäck, 2005, Leukotriene B4 signaling through NF-κB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia, Proc. Natl. Acad. Sci. U.S.A., 102, 17501, 10.1073/pnas.0505845102 Bäck, 2006, Increased inflammatory circuits within the leukotriene pathway in atherosclerosis, Arch. Mal. Cœur Vaiss., 99, 342 Cipollone, 2005, Association between 5-lipoxygenase expression and plaque instability in humans, Arterioscler. Thromb. Vasc. Biol., 25, 1665, 10.1161/01.ATV.0000172632.96987.2d Carry, 1992, Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation, Circulation, 85, 230, 10.1161/01.CIR.85.1.230 Helgadottir, 2004, The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke, Nat. Genet., 36, 233, 10.1038/ng1311 Hoffmann, 2000, Coronary in-stent restenosis predictors, treatment and prevention, Eur. Heart. J., 21, 1739, 10.1053/euhj.2000.2153 Zhao, 2004, The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm, Nat. Med., 10, 966, 10.1038/nm1099 Fontaine, 2004, Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus, Am. J. Pathol., 164, 2077, 10.1016/S0002-9440(10)63766-2 Stanke-Labesque, 2000, Angiotensin II-induced contractions in human internal mammary artery : effects of cyclooxy-genase and lipoxygenase inhibition, Cardiovasc. Res., 47, 376, 10.1016/S0008-6363(00)00112-7 Dahlén, 2001, Leukotriene receptors : functional aspects and future targets, Clin. Exp. Allergy. Rev., 1, 137, 10.1046/j.1472-9725.2001.00025.x Hakonarson, 2005, Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction : arandomized trial, JAMA, 293, 2245, 10.1001/jama.293.18.2245